Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.0%

3 terminated/withdrawn out of 25 trials

Success Rate

82.4%

-4.2% vs industry average

Late-Stage Pipeline

16%

4 trials in Phase 3/4

Results Transparency

36%

5 of 14 completed trials have results

Key Signals

5 recruiting5 with results

Enrollment Performance

Analytics

Phase 1

4(22.2%)

N/A

4(22.2%)

Phase 2

4(22.2%)

Early Phase 1

2(11.1%)

Phase 4

2(11.1%)

Phase 3

2(11.1%)

18Total

Phase 1(4)

N/A(4)

Phase 2(4)

Early Phase 1(2)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (25)

Showing 20 of 25 trials

NCT04264897Phase 3Completed

Antecedent Metabolic Health and Metformin Aging Study

Role: lead

NCT06507189Not ApplicableRecruiting

Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX)

Role: collaborator

NCT05483465Phase 4Recruiting

The Effect of NAD Supplementation on Brain Vascular Health in Aging

Role: collaborator

NCT07500727Not ApplicableRecruiting

Skeletal Muscle Aging and Responsiveness in Aged People With MS

Role: lead

NCT05537298Recruiting

Muscle Recovery After Critical Illness

Role: collaborator

NCT06828159Not ApplicableRecruiting

Dietary Wild Blueberries and Joint Health

Role: collaborator

NCT03355482Phase 2Terminated

MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE

Role: lead

NCT04523246Early Phase 1Completed

Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents

Role: collaborator

NCT04726553Early Phase 1Unknown

Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE

Role: lead

NCT03746028Unknown

The Lupus prEGnAnCY Cohort: An International Prospective Cohort of Lupus Pregnancies

Role: collaborator

NCT02270957Phase 2Completed

Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches

Role: lead

NCT04403594Completed

Functional Intermuscular Reduction of Spasticity

Role: collaborator

NCT01781611Not ApplicableTerminated

Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)

Role: lead

NCT00594932Phase 1Completed

Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis

Role: lead

NCT01506661Phase 1Completed

Safety of Zostavax Vaccination in Rheumatoid Arthritis

Role: lead

NCT02917265Phase 2Terminated

Transcutaneous Vagus Nerve Stimulation for the Treatment of Lupus

Role: collaborator

NCT01807689Completed

Salivary Biomarkers for Sjögren's Syndrome Detection

Role: collaborator

NCT01213017Phase 3Completed

The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients

Role: lead

NCT02270970Phase 4Unknown

Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacy

Role: lead

NCT00071175Completed

Lupus Genetics Studies

Role: lead